The KRASG12C inhibitors in lung cancer therapy

Introduction: Lung cancer is characterized by the highest mortality among cancers and is the second most frequently diagnosed type of cancer in the world. Targeted therapies are a promising therapeutic option for patients with this disease, however, one of the most common and most malignant mutation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maciej Jędrak (Autor), Karolina Niekurzak (Autor), Joanna Kania (Autor), Maciej Józefiak (Autor), Piotr Sobkiewicz (Autor), Krzysztof Kania (Autor)
Formato: Libro
Publicado: Kazimierz Wielki University, 2023-09-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible